Class 3 Medicines Recall: Theramex Hq UK Ltd, Evorel Sequi, El (24)a/41
Evorel Sequi Recall Summary Some packages of Evorel Sequi hormone replacement therapy patches contain the wrong combination of patches due to a packaging error. The affected packs have incorrect combinations of Evorel 50 and Evorel Conti patches instead of the correct mix. This recall affects Evorel Sequi distributed in the United Kingdom.
- Product
- Theramex has informed the MHRA that some cartons of Evorel Sequi contain the incorrect combination of patches. An error at the packaging site means that a limited number of packs have the incorrect combination of Evorel 50 and Evorel Conti patches.
- Reason
- Theramex has informed the MHRA that some cartons of Evorel Sequi contain the incorrect combination of patches. An error at the packaging site means that a limited number of packs have the incorrect combination of Evorel 50 and Evorel Conti patches.
- Classification
- Class II
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2024-09-12
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/72f4b9cf-08da-4b65-a480-0b9a2a99bfc0